Related Experiment Videos

Continuous ambulatory peritoneal dialysis: a three year experience

Insights

Continuous ambulatory peritoneal dialysis (CAPD) offers good patient survival and technique success for end-stage renal failure. CAPD patients maintained satisfactory biochemical control and blood pressure on a liberal diet, with many able to work.

Area of Science:

  • Nephrology
  • Renal Medicine
  • Dialysis Therapy

Background:

  • End-stage renal failure (ESRF) necessitates renal replacement therapy.
  • Continuous ambulatory peritoneal dialysis (CAPD) is a treatment option for ESRF patients.
  • Evaluating the long-term outcomes of CAPD is crucial for patient management.

Purpose of the Study:

  • To assess patient survival and technique success rates of CAPD.
  • To evaluate the efficacy of CAPD in biochemical and blood pressure control.
  • To identify common complications and their impact on hospitalization in CAPD patients.

Main Methods:

  • A prospective study of 66 patients with ESRF commencing CAPD over three years.
  • Monitoring of patient survival and technique success rates.
  • Assessment of biochemical parameters, blood pressure, and complication rates.

Main Results:

  • Two-year patient survival was 86%, and technique success was 64%.
  • Satisfactory biochemical and blood pressure control was achieved with a liberal diet, often without antihypertensive medication.
  • Common complications included peritonitis, catheter obstruction, postural hypotension, and weight gain, contributing to a mean hospitalization of 33 days per patient annually.

Conclusions:

  • CAPD demonstrates favorable patient survival and technique success in ESRF.
  • CAPD facilitates good metabolic and hemodynamic control, allowing for a liberal diet.
  • Despite complications, a significant proportion of patients, including older individuals and diabetics, remained employed.

Related Concept Videos